Professor Oliver Bathe examines how a new molecular test can lead to smarter decisions and better patient care outcomes in ...
Integral Molecular, a leader in antibody discovery and characterization, announces that its Membrane Proteome Array™ (MPA) ...
Ribosomes are the cell's protein factories, which read the genetic code and assemble the proteins that every organism needs ...
A major US study reveals that marijuana use leaves measurable chemical traces in DNA, altering genes related to mental health ...
Equitable access to genomic testing for NSCLC patients is vital for advanced therapy access, with strategies including ...
Stomach cancer is challenging to detect early due to vague symptoms, often diagnosed at advanced stages. Diagnosis involves ...
Panelists discussed these questions during a recent Institute for Value-Based Medicine® event held in Nashville, Tennessee, ...
The Las Vegas Medical District is set to expand with a new testing facility that officials say will strengthen the region’s ...
Improving Oncotype DX turnaround time for timeliness of adjuvant therapy: A single-system, multi-site quality improvement study in early-stage HR-positive breast cancer. This is an ASCO Meeting ...
PHILADELPHIA, Oct. 14, 2025 /PRNewswire/ -- Integral Molecular, a leader in developing innovative tools for antiviral research, announces the launch of its Ready Reporter Virus™ (RRV) neutralization ...
The FDA has granted breakthrough therapy designation to zenocutuzumab (Bizengri) for the treatment of patients with advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback